Study of IFN-K in Dermatomyositis

NCT02980198 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped reorganization proceedings with a potential risk of company liquidation

Conditions

Dermatomyositis

Interventions

BIOLOGICAL: IFN-Kinoid
OTHER: Placebo
OTHER: ISA 51

Sponsor

Neovacs